Midas (MDS) Shares Slide as CL King Downgrades to Neutral
More News related to MDS
- MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
- Midas Will Present at Gabelli Conference
- MDS Inc. Completes Divestiture of Central Labs Operations
- Midas Reports Third Quarter Earnings of $0.10 Per Diluted Share; 18 Percent Increase in Traffic at U.S. Midas Shops Offset by Decline in Average Ticket; 11 Additional Midas Shops Co-Branded During the
- MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies
More News related to Downgrades
- Davenport Downgrades Nokia (NOK) to Neutral
- Sidoti & Co Downgrades Innophos Holdings (IPHS) to Neutral
- Sidoti & Co Downgrades Tyler Technologies (TYL) to Neutral
- China BAK (CBAK) Shares Tumble Amid Q4 Results, Roth Capital Downgrade
- Canaccord Adams Downgrades Micromet (MITI) to Hold
Shares of Midas (NYSE: MDS) are falling today amid a downgrade from Strong Buy to Neutral over at CL King. The stock most recently traded at $10.23, down about 3.5% from yesterday's closing price.
To see all the analyst action on shares of Midas, visit our Analyst Ratings page.
Midas, Inc. provides retail automotive services principally through franchised, company-operated, or licensed shops in the United States, Canada, Europe, and internationally.
Related Categories
DowngradesStocks Mentioned
-0.05Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
